We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
-11.29%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.38B
AUM Growth
-$799M
Cap. Flow
-$109M
Cap. Flow %
-2.49%
Top 10 Hldgs %
5.78%
Holding
1,425
New
121
Increased
257
Reduced
318
Closed
105

Top Buys

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$21M
2
NUE icon
Nucor
NUE
+$15.4M
3
GIS icon
General Mills
GIS
+$13M
4
DOW icon
Dow Inc
DOW
+$11.2M
5
OXY icon
Occidental Petroleum
OXY
+$10.3M

Top Sells

Rank Stock Value
1
AR icon
Antero Resources
AR
+$17.7M
2
CL icon
Colgate-Palmolive
CL
+$15.8M
3
NSC icon
Norfolk Southern
NSC
+$15.4M
4
WAT icon
Waters Corp
WAT
+$11M
5
NTAP icon
NetApp
NTAP
+$10.6M

Sector Composition

Rank Sector Weight
1 Financials 27.17%
2 Energy 10.91%
3 Industrials 10.83%
4 Consumer Discretionary 9.97%
5 Technology 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DXLG icon
1076
Destination XL Group
DXLG
$32.6M
$217K 0.01%
63,900
-299,300
-82% -$1.35M
EQ icon
1077
Equillium
EQ
$134M
$217K 0.01%
106,200
– –
GAIA icon
1078
Gaia
GAIA
$48.1M
$216K ﹤0.01%
50,800
-40,000
-44% -$194K
LBPH
1079
DELISTED
Longboard Pharmaceuticals, Inc. Common Stock
LBPH
$216K ﹤0.01%
70,000
– –
EIGR
1080
DELISTED
Eiger BioPharmaceuticals, Inc.
EIGR
$214K ﹤0.01%
1,130
-2,000
-64% -$403K
LFMD icon
1081
LifeMD
LFMD
$164M
$211K ﹤0.01%
103,206
+28,206
+38% +$70.1K
CNVS icon
1082
Cineverse
CNVS
$62.3M
$209K ﹤0.01%
21,225
– –
CAMP
1083
DELISTED
CalAmp Corp.
CAMP
$209K ﹤0.01%
2,174
-2,261
-51% -$315K
CYT
1084
DELISTED
Cyteir Therapeutics, Inc. Common Stock
CYT
$208K ﹤0.01%
+69,584
New +$178K
HZN
1085
DELISTED
Horizon Global Corporation
HZN
$208K ﹤0.01%
127,800
– –
CMTL icon
1086
Comtech Telecommunications
CMTL
$51.5M
$204K ﹤0.01%
+22,500
New +$281K
EYPT icon
1087
EyePoint Inc
EYPT
$1.08B
$204K ﹤0.01%
25,900
-34,500
-57% -$347K
CARM
1088
DELISTED
Carisma Therapeutics
CARM
$203K ﹤0.01%
12,500
– –
UG icon
1089
United-Guardian
UG
$33.3M
$202K ﹤0.01%
13,466
– –
TACT icon
1090
Transact Technologies
TACT
$58.4M
$200K ﹤0.01%
49,623
+12,000
+32% +$66.4K
PTVE
1091
DELISTED
Pactiv Evergreen Inc. Common stock
PTVE
$199K ﹤0.01%
+20,000
New +$201K
SCTL
1092
DELISTED
Societal CDMO, Inc. Common Stock
SCTL
$198K ﹤0.01%
249,600
– –
QTTB icon
1093
Q32 Bio
QTTB
$482M
$196K ﹤0.01%
5,528
-2,778
-33% -$94.8K
ETNB
1094
DELISTED
89bio
ETNB
$194K ﹤0.01%
60,300
– –
AWRE icon
1095
Aware
AWRE
$26.8M
$192K ﹤0.01%
80,679
– –
FKWL icon
1096
Franklin Wireless
FKWL
$26.8M
$192K ﹤0.01%
59,300
-700
-1% -$2.46K
PTN
1097
Palatin Technologies
PTN
$14M
$192K ﹤0.01%
546
– –
CTEK
1098
DELISTED
CynergisTek, Inc.
CTEK
$192K ﹤0.01%
159,900
-10,100
-6% -$10.3K
SRAX
1099
DELISTED
SRAX, Inc. Class A Common Stock
SRAX
$190K ﹤0.01%
+57,100
New +$211K
IMRX icon
1100
Immuneering
IMRX
$289M
$189K ﹤0.01%
+34,949
New +$186K
42 43
44
45 46

Similar funds

SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return

Bridgeway Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Bridgeway Capital Management held 1,425 positions worth $4.38B, down 15% from $5.17B the previous quarter. Its ten largest holdings account for 5.8% of the portfolio.

Bridgeway Capital Management's Q2 2022 filing shows 121 new, 257 increased, 318 reduced and 105 closed positions. Its largest new stake was Charles River Laboratories: 86,100 shares worth $18.4M. The largest sale was Antero Resources, an estimated $17.7M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Energy and Industrials.

  • Bridgeway Capital Management's largest Q2 2022 buy was Charles River Laboratories: 86,100 shares worth $18.4M.
  • Bridgeway Capital Management added most to Nucor in Q2 2022, an estimated $15.4M increase.
  • Bridgeway Capital Management's biggest Q2 2022 reduction was Antero Resources, cutting an estimated $17.7M.
  • Bridgeway Capital Management fully exited Colgate-Palmolive in Q2 2022, selling an estimated $15.8M.
  • Bridgeway Capital Management's ten largest holdings make up 5.8% of its $4.38B portfolio in Q2 2022.
  • Bridgeway Capital Management opened 121 new positions and closed 105 in Q2 2022.
  • Bridgeway Capital Management's portfolio value fell 15% quarter-over-quarter to $4.38B.

Based on Bridgeway Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.